1. Tisotumab vedotin in Japanese patients with recurrent/metastatic cervical cancer: Results from the innovaTV 206 study
   Kan Yonemori et al, 2022, Cancer Science CrossRef
2. Place des thérapies innovantes dans la prise en charge des cancers du col de l’utérus
   Diana Bello Roufai, 2024, Bulletin du Cancer CrossRef
3. Establishment and validation of a predictive nomogram for central venous catheter-related thrombosis in cancer patients: a retrospective nested case-control study
   Xuexing Wang et al, 2024, Frontiers in Oncology CrossRef
4. Exposure‐safety and exposure‐efficacy analyses for tisotumab vedotin for patients with locally advanced or metastatic solid tumors
   Chaitali Passey et al, 2023, CPT: Pharmacometrics & Systems Pharmacology CrossRef
5. Novel Therapeutics for Recurrent Cervical Cancer: Moving Towards Personalized Therapy
   Alexander C. Cohen et al, 2020, Drugs CrossRef
6. A review of recent advances on single use of antibody-drug conjugates or combination with tumor immunology therapy for gynecologic cancer
   An-Jin Wang et al, 2022, Frontiers in Pharmacology CrossRef
7. Review of emerging biological therapies for recurrent and advanced metastatic cervical cancer
   Virginia E. Fontenot et al, 2024, Expert Opinion on Biological Therapy CrossRef